Lung Therapeutics Competitors and Similar CompaniesClear all
Lung Therapeutics's competitors and similar companies include TFF Pharmaceuticals, Praedicare Labs, ReViral, FibroGen, Nuvaira and Sanovas.
 Lung Therapeutics Lung Therapeutics is a biopharmaceutical company developing medicines for unmet medical needs in fibrosis and lung disease. |  TFF Pharmaceuticals TFF Pharmaceuticals is a biopharmaceutical company focused on developing drug products based on the Thin Film Freezing (TFF) technology platform. |  Praedicare Labs Praedicare Labs is a company providing drug development services for pre-clinical and early clinical phases. |  FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. |  Sanovas Sanovas offers micro-invasive devices and drug delivery technologies for the treatment of lung and pulmonary diseases. | |||
Founding Date | Founding Date 2013 | Founding Date 2018 | Founding Date 2018 | Founding Date 2011 | Founding Date 1993 | Founding Date 2008 | Founding Date 2009 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||||
Locations | Locations Austin, US HQ | Locations Austin, US HQ | Locations Farmers Branch, US HQ | Locations Stevenage, GB HQ Durham, US | Locations San Francisco, US HQ | Locations Plymouth, US HQ Maple Grove, US | Locations Petaluma, US HQ San Rafael, US |
Employees | Employees 10 | Employees 1927% increase | Employees 814% increase | Employees 5 | Employees 53115% increase | Employees 2212% decrease | Employees 15 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 30.7 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $733.9k (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $6.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($21.2m) (FY, 2023) | Net income N/A | Net income N/A | Net income $183.5m (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||||
Latest funding round | Latest funding round $ 36m (about 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 44m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 79m (over 7 years ago) | Latest funding round $ 285.7k (over 10 years ago) |
Total funding raised | Total funding raised $ 53.9m | Total funding raised $ 22.3m | Total funding raised N/A | Total funding raised $ 121m | Total funding raised N/A | Total funding raised $ 147.6m | Total funding raised $ 6.7m |
For sources of this data, please see the company profile
View Company Profiles
TFF Pharmaceuticals
HQ
Austin, US
Employees
19↑ 27% increase
TFF Pharmaceuticals is a biopharmaceutical company focused on developing drug products based on the Thin Film Freezing (TFF) technology platform.
View companyPraedicare Labs
HQ
Farmers Branch, US
Employees
8↑ 14% increase
Praedicare Labs is a company providing drug development services for pre-clinical and early clinical phases.
View company
ReViral
HQ
Stevenage, GB
Employees
5
ReViral is a biotechnology company developing drugs to treat RSV infections.
View companyFibroGen
HQ
San Francisco, US
Employees
531↑ 15% increase
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View company